Found: 133
Select item for more details and to access through your institution.
Innovative Approaches in the Treatment and Management of Heart Failure: Managed Care Considerations on the Role of New and Emerging Therapies.
- Published in:
- Journal of Managed Care Medicine, 2024, v. 27, n. 2, p. 8
- By:
- Publication type:
- Article
Topological-derivative-based design of stiff fiber-reinforced structures with optimally oriented continuous fibers.
- Published in:
- Structural & Multidisciplinary Optimization, 2021, v. 63, n. 2, p. 703, doi. 10.1007/s00158-020-02721-1
- By:
- Publication type:
- Article
Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trial.
- Published in:
- Diabetologia, 2018, v. 61, n. 3, p. 581, doi. 10.1007/s00125-017-4485-y
- By:
- Publication type:
- Article
A multi-site randomized trial of a clinical decision support intervention to improve problem list completeness.
- Published in:
- Journal of the American Medical Informatics Association, 2023, v. 30, n. 5, p. 899, doi. 10.1093/jamia/ocad020
- By:
- Publication type:
- Article
Are institutional review boards prepared for active continuing review?
- Published in:
- Perspectives in Clinical Research, 2014, v. 5, n. 1, p. 11, doi. 10.4103/2229-3485.124553
- By:
- Publication type:
- Article
Implantable Defibrillators for the Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-analysis of Randomized Controlled Trials.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 292, n. 23, p. 2874, doi. 10.1001/jama.292.23.2874
- By:
- Publication type:
- Article
Systems biology approach to stage-wise characterization of epigenetic genes in lung adenocarcinoma.
- Published in:
- BMC Systems Biology, 2013, v. 7, n. 1, p. 2, doi. 10.1186/1752-0509-7-141
- By:
- Publication type:
- Article
ATS Core Curriculum 2014: Part II. Adult Critical Care Medicine.
- Published in:
- Annals of the American Thoracic Society, 2014, v. 11, n. 8, p. 1307, doi. 10.1513/AnnalsATS.201407-322CME
- By:
- Publication type:
- Article
Extraction of Ejection Fraction from Echocardiography Notes for Constructing a Cohort of Patients having Heart Failure with reduced Ejection Fraction (HFrEF).
- Published in:
- Journal of Medical Systems, 2018, v. 42, n. 11, p. 1, doi. 10.1007/s10916-018-1066-7
- By:
- Publication type:
- Article
2-OR: Impact of N Terminal Pro B-Type Natriuretic Peptide and High Sensitivity Cardiac Troponin on the Prediction of Death and Cardiovascular Events in High-Risk Patients with Type 2 Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-2-OR
- By:
- Publication type:
- Article
Left Ventricular Assist Device Withdrawal: Ethical, Psychological, and Logistical Challenges.
- Published in:
- Journal of Palliative Medicine, 2020, v. 23, n. 4, p. 456, doi. 10.1089/jpm.2019.0622
- By:
- Publication type:
- Article
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prognostic value of brain natriuretic peptide vs history of heart failure hospitalization in a large real‐world population.
- Published in:
- Clinical Cardiology, 2020, v. 43, n. 12, p. 1501, doi. 10.1002/clc.23468
- By:
- Publication type:
- Article
Rationale and design of a navigator‐driven remote optimization of guideline‐directed medical therapy in patients with heart failure with reduced ejection fraction.
- Published in:
- Clinical Cardiology, 2020, v. 43, n. 1, p. 4, doi. 10.1002/clc.23291
- By:
- Publication type:
- Article
Patients report more severe daily limitations than recognized by their physicians.
- Published in:
- Clinical Cardiology, 2019, v. 42, n. 12, p. 1181, doi. 10.1002/clc.23269
- By:
- Publication type:
- Article
Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 31, p. 2930, doi. 10.1093/eurheartj/ehad283
- By:
- Publication type:
- Article
Stroke in patients with heart failure and reduced or preserved ejection fraction.
- Published in:
- European Heart Journal, 2023, v. 44, n. 31, p. 2998, doi. 10.1093/eurheartj/ehad338
- By:
- Publication type:
- Article
Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF.
- Published in:
- European Heart Journal, 2023, v. 44, n. 31, p. 2982, doi. 10.1093/eurheartj/ehad344
- By:
- Publication type:
- Article
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER.
- Published in:
- European Heart Journal, 2023, v. 44, n. 24, p. 2170, doi. 10.1093/eurheartj/ehad276
- By:
- Publication type:
- Article
Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 24, p. 2202, doi. 10.1093/eurheartj/ehad210
- By:
- Publication type:
- Article
Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox.
- Published in:
- European Heart Journal, 2023, v. 44, n. 13, p. 1136, doi. 10.1093/eurheartj/ehad083
- By:
- Publication type:
- Article
Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction.
- Published in:
- European Heart Journal, 2023, v. 44, n. 8, p. 668, doi. 10.1093/eurheartj/ehac801
- By:
- Publication type:
- Article
Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation.
- Published in:
- European Heart Journal, 2022, v. 43, n. 42, p. 4469, doi. 10.1093/eurheartj/ehac487
- By:
- Publication type:
- Article
Dapagliflozin for heart failure according to body mass index: the DELIVER trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4406, doi. 10.1093/eurheartj/ehac481
- By:
- Publication type:
- Article
GUIDE-HF trial of pulmonary artery pressure monitoring in heart failure: impact of the COVID-19 pandemic.
- Published in:
- European Heart Journal, 2022, v. 43, n. 27, p. 2603, doi. 10.1093/eurheartj/ehac114
- By:
- Publication type:
- Article
Accelerated and personalized therapy for heart failure with reduced ejection fraction.
- Published in:
- European Heart Journal, 2022, v. 43, n. 27, p. 2573, doi. 10.1093/eurheartj/ehac210
- By:
- Publication type:
- Article
Geographical variation in patient characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 8, p. 1788, doi. 10.1002/ejhf.3352
- By:
- Publication type:
- Article
Cardiovascular‐kidney‐metabolic overlap in heart failure with preserved ejection fraction: Cardiac structure and function, clinical outcomes, and response to sacubitril/valsartan in PARAGON‐HF.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 8, p. 1762, doi. 10.1002/ejhf.3304
- By:
- Publication type:
- Article
Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose‐lowering therapy: A pre‐specified analysis of the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 7, p. 1539, doi. 10.1002/ejhf.3269
- By:
- Publication type:
- Article
Dapagliflozin and quality of life measured using the EuroQol 5‐dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 7, p. 1524, doi. 10.1002/ejhf.3263
- By:
- Publication type:
- Article
Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS‐HF trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 6, p. 1324, doi. 10.1002/ejhf.3253
- By:
- Publication type:
- Article
Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS‐HF trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 6, p. 1334, doi. 10.1002/ejhf.3266
- By:
- Publication type:
- Article
Effects of sacubitril/valsartan according to polypharmacy status in PARAGON‐HF.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 5, p. 1125, doi. 10.1002/ejhf.3223
- By:
- Publication type:
- Article
Dapagliflozin in patients with heart failure and previous myocardial infarction: A participant‐level pooled analysis of DAPA‐HF and DELIVER.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 912, doi. 10.1002/ejhf.3184
- By:
- Publication type:
- Article
Independent prognostic importance of blood urea nitrogen to creatinine ratio in heart failure.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 2, p. 245, doi. 10.1002/ejhf.3114
- By:
- Publication type:
- Article
Impact of COVID‐19 in patients with heart failure with mildly reduced or preserved ejection fraction enrolled in the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 12, p. 2177, doi. 10.1002/ejhf.3043
- By:
- Publication type:
- Article
Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 12, p. 2202, doi. 10.1002/ejhf.3044
- By:
- Publication type:
- Article
Knowledge about self‐efficacy and outcomes in patients with heart failure and reduced ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 10, p. 1831, doi. 10.1002/ejhf.2944
- By:
- Publication type:
- Article
Influence of background medical therapy on efficacy and safety of dapagliflozin in patients with heart failure with improved ejection fraction in the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 9, p. 1663, doi. 10.1002/ejhf.3001
- By:
- Publication type:
- Article
Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with reduced and preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 9, p. 1606, doi. 10.1002/ejhf.2962
- By:
- Publication type:
- Article
Effects of dapagliflozin on heart failure hospitalizations according to severity of inpatient course: Insights from DELIVER and DAPA‐HF.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1364, doi. 10.1002/ejhf.2912
- By:
- Publication type:
- Article
Incremental prognostic value of biomarkers in PARADIGM‐HF.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1406, doi. 10.1002/ejhf.2887
- By:
- Publication type:
- Article
Clinical characteristics of heart failure with reduced ejection fraction patients with rare pathogenic variants in dilated cardiomyopathy‐associated genes: A subgroup analysis of the PARADIGM‐HF trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1256, doi. 10.1002/ejhf.2886
- By:
- Publication type:
- Article
Renal and blood pressure effects of dapagliflozin in recently hospitalized patients with heart failure with mildly reduced or preserved ejection fraction: Insights from the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 7, p. 1170, doi. 10.1002/ejhf.2915
- By:
- Publication type:
- Article
Effect of dapagliflozin on health status and quality of life across the spectrum of ejection fraction: Participant‐level pooled analysis from the DAPA‐HF and DELIVER trials.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 7, p. 981, doi. 10.1002/ejhf.2909
- By:
- Publication type:
- Article
Impact of multimorbidity on mortality in heart failure with reduced ejection fraction: which comorbidities matter most? An analysis of PARADIGM‐HF and ATMOSPHERE.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 5, p. 687, doi. 10.1002/ejhf.2856
- By:
- Publication type:
- Article
Association of post‐vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high‐risk cardiovascular disease: the INVESTED trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 2, p. 299, doi. 10.1002/ejhf.2716
- By:
- Publication type:
- Article
Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON‐HF trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 1, p. 87, doi. 10.1002/ejhf.2703
- By:
- Publication type:
- Article